Eledon Pharmaceuticals News - ELDN

Company Name	Stock Ticker Symbol	Market	Type
Eledon Pharmaceuticals Inc	ELDN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.10	-4.10%	2.34	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
2.43	2.27	2.49	2.40	2.44

more quote information »

Recent News

Date	Time	Source	Heading
5/09/2024	07:30	GLOBE	Eledon Pharmaceuticals Reports First Quarter 2024 Operating..
5/09/2024	07:00	GLOBE	Eledon Pharmaceuticals to Present Updated Data from Ongoing..
5/07/2024	07:15	EDGAR2	Form 8-K - Current report
5/07/2024	07:05	GLOBE	Eledon Announces Clinical Progress with Tegoprubart in the..
5/07/2024	07:00	GLOBE	Eledon Pharmaceuticals Announces Oversubscribed $50 Million..
3/28/2024	16:01	GLOBE	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year..
3/25/2024	16:56	GLOBE	Eledon Pharmaceuticals Announces 12th Participant Enrolled..
3/21/2024	10:31	GLOBE	Eledon Pharmaceuticals Announces Use of Tegoprubart in..
2/14/2024	15:35	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	15:01	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	19:01	GLOBE	Eledon Reports Inducement Grants Under Nasdaq Listing Rule..
1/04/2024	16:40	GLOBE	Eledon Pharmaceuticals Highlights Recent Business Milestones..
12/04/2023	18:00	GLOBE	Eledon Reports Inducement Grants Under Nasdaq Listing Rule..
11/29/2023	16:05	GLOBE	Eledon Pharmaceuticals to Present at Noble Capital Markets'..
11/09/2023	17:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:01	GLOBE	Eledon Pharmaceuticals Reports Third Quarter 2023 Operating..
11/08/2023	16:05	GLOBE	Eledon Pharmaceuticals to Present at Jefferies London..
11/02/2023	16:30	EDGAR2	Form 8-K - Current report
11/02/2023	09:05	GLOBE	Eledon Reports Updated Data from Ongoing Phase 1b Trial..
10/23/2023	07:00	GLOBE	Eledon Pharmaceuticals Strengthens Leadership Team with..
10/13/2023	07:00	GLOBE	Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b..
10/03/2023	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	17:51	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/02/2023	17:08	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/02/2023	07:30	EDGAR2	Form 8-K - Current report
10/02/2023	07:00	GLOBE	Eledon Pharmaceuticals Appoints Kidney Transplant Specialist..
9/25/2023	07:00	GLOBE	Eledon Pharmaceuticals Announces Use of Tegoprubart..
9/20/2023	16:05	GLOBE	Eledon Pharmaceuticals to Participate at the 2023 Cantor..
9/13/2023	16:42	EDGAR2	Form 8-K - Current report
9/11/2023	07:00	GLOBE	Eledon Pharmaceuticals Appoints Industry Veteran James..
9/06/2023	07:00	GLOBE	Eledon Pharmaceuticals Announces Publication of Data Showing..
9/05/2023	07:00	GLOBE	Eledon Pharmaceuticals Announces First Participant Dosed in..
8/16/2023	07:00	GLOBE	Eledon Pharmaceuticals Announces Dosing of 10th Patient in..
8/10/2023	17:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	07:05	EDGAR2	Form 8-K - Current report
8/10/2023	07:00	GLOBE	Eledon Pharmaceuticals Reports Second Quarter 2023 Operating..
6/02/2023	08:00	GLOBE	Eledon Pharmaceuticals to Present at Jefferies Healthcare..
5/11/2023	16:01	GLOBE	Eledon Pharmaceuticals Reports First Quarter 2023 Operating..